Author:
Lei Y,Henderson B R,Emmanuel C,Harnett P R,deFazio A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference67 articles.
1. Guminski AD, Harnett PR, deFazio A . Scientists and clinicians test their metal-back to the future with platinum compounds. Lancet Oncol 2002; 3: 312–318.
2. Sasaki H, Sheng Y, Kotsuji F, Tsang BK . Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 2000; 60: 5659–5666.
3. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 2001; 142: 370–380.
4. Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB . Inhibition of phosphatidylinositol 3′-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Cancer Res 2002; 62: 1087–1092.
5. Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ . AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 2003; 278: 23432–23440.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献